[
  {
    "ts": null,
    "headline": "Stock Market Today, Dec. 16: Pfizer Falls After Cutting 2025 Revenue Forecast",
    "summary": "Today, Dec. 16, 2025, Pfizer's shrinking COVID cash flows could mean little growth next year as M&A bets will take time to deliver.",
    "url": "https://finnhub.io/api/news?id=c9796abd71cdb84504ea07bde9c430766b017d06e13c0c8755cc60745cfbb2e8",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1765926221,
      "headline": "Stock Market Today, Dec. 16: Pfizer Falls After Cutting 2025 Revenue Forecast",
      "id": 137806038,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Today, Dec. 16, 2025, Pfizer's shrinking COVID cash flows could mean little growth next year as M&A bets will take time to deliver.",
      "url": "https://finnhub.io/api/news?id=c9796abd71cdb84504ea07bde9c430766b017d06e13c0c8755cc60745cfbb2e8"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer (PFE) Registers a Bigger Fall Than the Market: Important Facts to Note",
    "summary": "In the latest trading session, Pfizer (PFE) closed at $25.57, marking a -3.27% move from the previous day.",
    "url": "https://finnhub.io/api/news?id=ab0c5484555dc981460282e7249d631588f9c3ab62577ab1b7f465825fcba495",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1765925104,
      "headline": "Pfizer (PFE) Registers a Bigger Fall Than the Market: Important Facts to Note",
      "id": 137806415,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "In the latest trading session, Pfizer (PFE) closed at $25.57, marking a -3.27% move from the previous day.",
      "url": "https://finnhub.io/api/news?id=ab0c5484555dc981460282e7249d631588f9c3ab62577ab1b7f465825fcba495"
    }
  },
  {
    "ts": null,
    "headline": "Dow, S&P 500 Fall For Third Straight Day Following Jobs Report",
    "summary": "The Dow Jones Industrial Average and the S&P 500 fell for a third straight session on Tuesday as tra",
    "url": "https://finnhub.io/api/news?id=8741e77f49811cfa519f01d1b64ece0eb7ddef312c5176bb231311803e34842b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1765921796,
      "headline": "Dow, S&P 500 Fall For Third Straight Day Following Jobs Report",
      "id": 137806391,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "The Dow Jones Industrial Average and the S&P 500 fell for a third straight session on Tuesday as tra",
      "url": "https://finnhub.io/api/news?id=8741e77f49811cfa519f01d1b64ece0eb7ddef312c5176bb231311803e34842b"
    }
  },
  {
    "ts": null,
    "headline": "Stock Market Today: Dow Slides, Nasdaq Positive After Jobs Data; Nvidia Rises (Live Coverage)",
    "summary": "Stock Market Today: The Dow Jones index dropped Tuesday after a surprise November jobs report. Palantir and Tesla traded lower.",
    "url": "https://finnhub.io/api/news?id=8c7e522fc56704e92653587ab5799dd4c4c470580979ce861fb9df6a197b93b0",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1765920258,
      "headline": "Stock Market Today: Dow Slides, Nasdaq Positive After Jobs Data; Nvidia Rises (Live Coverage)",
      "id": 137805811,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Stock Market Today: The Dow Jones index dropped Tuesday after a surprise November jobs report. Palantir and Tesla traded lower.",
      "url": "https://finnhub.io/api/news?id=8c7e522fc56704e92653587ab5799dd4c4c470580979ce861fb9df6a197b93b0"
    }
  },
  {
    "ts": null,
    "headline": "Monte Rosa Scores A Win In Prostate Cancer, And Rockets To A Four-Year High",
    "summary": "Monte Rosa Therapeutics surged Tuesday after the biotech said every patients in a prostate cancer study responded to its treatment.",
    "url": "https://finnhub.io/api/news?id=5b5ea689ffadfc6d562f5a3e32b2d3ecdd73ce0abde1fe14635aec84359f29a7",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1765920060,
      "headline": "Monte Rosa Scores A Win In Prostate Cancer, And Rockets To A Four-Year High",
      "id": 137806418,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Monte Rosa Therapeutics surged Tuesday after the biotech said every patients in a prostate cancer study responded to its treatment.",
      "url": "https://finnhub.io/api/news?id=5b5ea689ffadfc6d562f5a3e32b2d3ecdd73ce0abde1fe14635aec84359f29a7"
    }
  },
  {
    "ts": null,
    "headline": "Why Pfizer's 2026 Guidance Miss Is 'Not A Major Surprise'",
    "summary": "Pfizer stock tumbled Tuesday after the drugmaker missed Wall Street's earnings forecast following a suite of acquisitions.",
    "url": "https://finnhub.io/api/news?id=a56f87d750ec873946ff34bb40fcf848195850bf93fd6427d9ca51ed850911fa",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1765919971,
      "headline": "Why Pfizer's 2026 Guidance Miss Is 'Not A Major Surprise'",
      "id": 137806419,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Pfizer stock tumbled Tuesday after the drugmaker missed Wall Street's earnings forecast following a suite of acquisitions.",
      "url": "https://finnhub.io/api/news?id=a56f87d750ec873946ff34bb40fcf848195850bf93fd6427d9ca51ed850911fa"
    }
  },
  {
    "ts": null,
    "headline": "These Stocks Moved the Most Today: Tesla, Pfizer, Humana, Circle, CoreWeave, Broadcom, IonQ, Ford, Navan, and More",
    "summary": "Stocks were mixed Tuesday as U.S. hiring in November was stronger than expected and the unemployment rate jumped to 4.6%.  Ford  was up 0.2%.  The auto maker announced a pivot toward hybrids and away from electric cars.",
    "url": "https://finnhub.io/api/news?id=9b7e09ee486694794212e16aa54500bf3deba29b3936b1c65d0221e8f44eb36b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1765919880,
      "headline": "These Stocks Moved the Most Today: Tesla, Pfizer, Humana, Circle, CoreWeave, Broadcom, IonQ, Ford, Navan, and More",
      "id": 137805920,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Stocks were mixed Tuesday as U.S. hiring in November was stronger than expected and the unemployment rate jumped to 4.6%.  Ford  was up 0.2%.  The auto maker announced a pivot toward hybrids and away from electric cars.",
      "url": "https://finnhub.io/api/news?id=9b7e09ee486694794212e16aa54500bf3deba29b3936b1c65d0221e8f44eb36b"
    }
  },
  {
    "ts": null,
    "headline": "Tepid 2026 outlook dents Pfizer shares",
    "summary": "Pfizer signaled Tuesday it expects a challenging 2026 as it invests in new products to offset declines in Covid-19 revenues while limiting shareholder payouts.The drugmaker expects a drop of $1.5 billion in 2026 revenues tied to lower Covid-19 sales and the decline of another $1.5 billion from products experiencing a loss of exclusivity.",
    "url": "https://finnhub.io/api/news?id=b4887492a57cae4af034e824d375bd98f462351698c7c664fee282c2fdcbf73a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1765918986,
      "headline": "Tepid 2026 outlook dents Pfizer shares",
      "id": 137806421,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Pfizer signaled Tuesday it expects a challenging 2026 as it invests in new products to offset declines in Covid-19 revenues while limiting shareholder payouts.The drugmaker expects a drop of $1.5 billion in 2026 revenues tied to lower Covid-19 sales and the decline of another $1.5 billion from products experiencing a loss of exclusivity.",
      "url": "https://finnhub.io/api/news?id=b4887492a57cae4af034e824d375bd98f462351698c7c664fee282c2fdcbf73a"
    }
  },
  {
    "ts": null,
    "headline": "Sector Update: Health Care Stocks Retreat Late Afternoon",
    "summary": "Health care stocks declined late Tuesday afternoon, with the NYSE Health Care Index falling 1.6% and",
    "url": "https://finnhub.io/api/news?id=36390b5a941276368cc94bd125809c11000b72c05969ba90011147e0800e78d7",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1765918802,
      "headline": "Sector Update: Health Care Stocks Retreat Late Afternoon",
      "id": 137806230,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Health care stocks declined late Tuesday afternoon, with the NYSE Health Care Index falling 1.6% and",
      "url": "https://finnhub.io/api/news?id=36390b5a941276368cc94bd125809c11000b72c05969ba90011147e0800e78d7"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer outlook, Humana leadership shake-up, Kraft Heinz's new CEO",
    "summary": "Pfizer (PFE), Humana (HUM), and Kraft Heinz (KHC) are some of the trending tickers on Yahoo Finance's platform on Tuesday. Market Domination host Josh Lipton and Yahoo Finance Senior Reporter Brooke DiPalma examine the stories driving investor interest in the names. To watch more expert insights and analysis on the latest market action, check out more Market Domination.",
    "url": "https://finnhub.io/api/news?id=56b8d050c792c10a3c0b2250ef65e2f09be96b543ea7d9ccda84a81799ac397d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1765917443,
      "headline": "Pfizer outlook, Humana leadership shake-up, Kraft Heinz's new CEO",
      "id": 137806423,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Pfizer (PFE), Humana (HUM), and Kraft Heinz (KHC) are some of the trending tickers on Yahoo Finance's platform on Tuesday. Market Domination host Josh Lipton and Yahoo Finance Senior Reporter Brooke DiPalma examine the stories driving investor interest in the names. To watch more expert insights and analysis on the latest market action, check out more Market Domination.",
      "url": "https://finnhub.io/api/news?id=56b8d050c792c10a3c0b2250ef65e2f09be96b543ea7d9ccda84a81799ac397d"
    }
  },
  {
    "ts": null,
    "headline": "Equities Fall Intraday as Markets Evaluate Macro Data",
    "summary": "US benchmark equity indexes were lower intraday as traders parsed the latest economic data, includin",
    "url": "https://finnhub.io/api/news?id=9e522cf50c9aebe422a339a2b590b65be4856519e7df1b78122df91166446fde",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1765912552,
      "headline": "Equities Fall Intraday as Markets Evaluate Macro Data",
      "id": 137806392,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "US benchmark equity indexes were lower intraday as traders parsed the latest economic data, includin",
      "url": "https://finnhub.io/api/news?id=9e522cf50c9aebe422a339a2b590b65be4856519e7df1b78122df91166446fde"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer trims 2026 profit forecast amid Covid headwinds and patent cliff pressures",
    "summary": "Alongside its cost-cutting strategy, Pfizer has been investing into its cardiometabolic pipeline in a bid to enter the lucrative obesity market.",
    "url": "https://finnhub.io/api/news?id=1baee72842ddb35551ac33b2116913674475a78ba20922027e9ef3906c4bb46b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1765910352,
      "headline": "Pfizer trims 2026 profit forecast amid Covid headwinds and patent cliff pressures",
      "id": 137806425,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Alongside its cost-cutting strategy, Pfizer has been investing into its cardiometabolic pipeline in a bid to enter the lucrative obesity market.",
      "url": "https://finnhub.io/api/news?id=1baee72842ddb35551ac33b2116913674475a78ba20922027e9ef3906c4bb46b"
    }
  },
  {
    "ts": null,
    "headline": "1 Bold Prediction for Viking Therapeutics in 2026",
    "summary": "Viking's pipeline may release its value next year, and larger companies are likely to consider acquiring it.",
    "url": "https://finnhub.io/api/news?id=2cdaf7aa13286f79e81fb527fb7510c6e07fcf10d6a9db8ea7ed09acbcab4288",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1765910100,
      "headline": "1 Bold Prediction for Viking Therapeutics in 2026",
      "id": 137806426,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Viking's pipeline may release its value next year, and larger companies are likely to consider acquiring it.",
      "url": "https://finnhub.io/api/news?id=2cdaf7aa13286f79e81fb527fb7510c6e07fcf10d6a9db8ea7ed09acbcab4288"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer (PFE): Reassessing Valuation After Cautious 2026 Outlook and Fading COVID-19 Revenue",
    "summary": "Pfizer (PFE) just laid out a 2026 outlook that underwhelmed the market, with lower expected earnings and revenue as COVID-19 sales fade and key drugs lose exclusivity, putting near term growth firmly under the microscope. See our latest analysis for Pfizer. Even with today’s dip on the 2026 guidance, Pfizer’s 90 day share price return of 10.59% suggests sentiment has been quietly improving, while the 1 year total shareholder return of 12.25% hints that long term confidence is slowly...",
    "url": "https://finnhub.io/api/news?id=ef804212cc5854b3635d927dededeb3c01ffbc3552a20c2c1afa60f3bb78a325",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1765908838,
      "headline": "Pfizer (PFE): Reassessing Valuation After Cautious 2026 Outlook and Fading COVID-19 Revenue",
      "id": 137806427,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Pfizer (PFE) just laid out a 2026 outlook that underwhelmed the market, with lower expected earnings and revenue as COVID-19 sales fade and key drugs lose exclusivity, putting near term growth firmly under the microscope. See our latest analysis for Pfizer. Even with today’s dip on the 2026 guidance, Pfizer’s 90 day share price return of 10.59% suggests sentiment has been quietly improving, while the 1 year total shareholder return of 12.25% hints that long term confidence is slowly...",
      "url": "https://finnhub.io/api/news?id=ef804212cc5854b3635d927dededeb3c01ffbc3552a20c2c1afa60f3bb78a325"
    }
  },
  {
    "ts": null,
    "headline": "Top Midday Stories: Pfizer Falls Following 2026 Outlook; Netflix-iHeartMedia Exclusive Deal; Apple's Possible iPhone Lineup Expansion",
    "summary": "All three major US stock indexes were pointing lower in late-morning trading on Tuesday, as investor",
    "url": "https://finnhub.io/api/news?id=b3b5d43c2c49f9b59b64c8c605c7aef21f3b70f8e7809a6f190091654653f277",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1765904924,
      "headline": "Top Midday Stories: Pfizer Falls Following 2026 Outlook; Netflix-iHeartMedia Exclusive Deal; Apple's Possible iPhone Lineup Expansion",
      "id": 137805835,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "All three major US stock indexes were pointing lower in late-morning trading on Tuesday, as investor",
      "url": "https://finnhub.io/api/news?id=b3b5d43c2c49f9b59b64c8c605c7aef21f3b70f8e7809a6f190091654653f277"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer CEO Defends Vaccines, Promises Growth by End of Decade",
    "summary": "Pfizer  CEO Albert Bourla called vaccine skepticism in the highest levels of the federal government “an anomaly” during an investor call on Tuesday.  “We will continue investing in vaccines because, as I said, this is an anomaly that will correct itself, I hope pretty soon,” Bourla said.  Pfizer shares were down 4.9% Tuesday to $25.13 after the company issued 2026 guidance that came in slightly below expectations and said it expects a return to growth at the end of the decade.",
    "url": "https://finnhub.io/api/news?id=b2893cff83d5a5977b4e0b4f71bcd6d29867128a563941d39b15c1f171cb9b1f",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1765904820,
      "headline": "Pfizer CEO Defends Vaccines, Promises Growth by End of Decade",
      "id": 137806429,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Pfizer  CEO Albert Bourla called vaccine skepticism in the highest levels of the federal government “an anomaly” during an investor call on Tuesday.  “We will continue investing in vaccines because, as I said, this is an anomaly that will correct itself, I hope pretty soon,” Bourla said.  Pfizer shares were down 4.9% Tuesday to $25.13 after the company issued 2026 guidance that came in slightly below expectations and said it expects a return to growth at the end of the decade.",
      "url": "https://finnhub.io/api/news?id=b2893cff83d5a5977b4e0b4f71bcd6d29867128a563941d39b15c1f171cb9b1f"
    }
  },
  {
    "ts": null,
    "headline": "Why Pfizer (PFE) Stock Is Sliding Today",
    "summary": "Pfizer Sees Revenue Decline, Shifts Focus to New Drugs",
    "url": "https://finnhub.io/api/news?id=b7f89ce134a61b2f7d8c5f7dc92d80cbb67413920450df003bb27c8cff9946e0",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1765903013,
      "headline": "Why Pfizer (PFE) Stock Is Sliding Today",
      "id": 137806430,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Pfizer Sees Revenue Decline, Shifts Focus to New Drugs",
      "url": "https://finnhub.io/api/news?id=b7f89ce134a61b2f7d8c5f7dc92d80cbb67413920450df003bb27c8cff9946e0"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer Sees 2026 Profit Below Estimates as COVID Sales Decline",
    "summary": "Loss of exclusivity and lower pandemic-related demand weigh on outlook.",
    "url": "https://finnhub.io/api/news?id=1d426e5a04581a4f008e53112281803d10f91b9e3f21e1074c8ace19fe6870bf",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1765901437,
      "headline": "Pfizer Sees 2026 Profit Below Estimates as COVID Sales Decline",
      "id": 137806431,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Loss of exclusivity and lower pandemic-related demand weigh on outlook.",
      "url": "https://finnhub.io/api/news?id=1d426e5a04581a4f008e53112281803d10f91b9e3f21e1074c8ace19fe6870bf"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer Q4 2026 Financial Guidance",
    "summary": "2025-12-16. The following slide deck was published by Pfizer Inc.",
    "url": "https://finnhub.io/api/news?id=0fbeb0db889ff0640c4d72f7edd5b62406e9a9bea609e9ed95599f339d8a7d49",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1765896787,
      "headline": "Pfizer Q4 2026 Financial Guidance",
      "id": 137804581,
      "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
      "related": "PFE",
      "source": "SeekingAlpha",
      "summary": "2025-12-16. The following slide deck was published by Pfizer Inc.",
      "url": "https://finnhub.io/api/news?id=0fbeb0db889ff0640c4d72f7edd5b62406e9a9bea609e9ed95599f339d8a7d49"
    }
  },
  {
    "ts": null,
    "headline": "Kraft Heinz taps new CEO, PayPal files for US bank charter",
    "summary": "Morning Brief host Julie Hyman tracks several of the day's top trending stock tickers, including Pfizer (PFE) expects flat sales growth in its 2026 forecast, Kraft Heinz (KHC) names former Kellanova (K) CEO Steve Cahillane as its next chief executive ahead of the food company's split, and PayPal (PYPL) filing for a US bank charter. To watch more expert insights and analysis on the latest market action, check out more Morning Brief.",
    "url": "https://finnhub.io/api/news?id=2194b41863459efcc3280e31a6eaf7be43ef215040cd4a6cc41900814a3dbcde",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1765896025,
      "headline": "Kraft Heinz taps new CEO, PayPal files for US bank charter",
      "id": 137806432,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Morning Brief host Julie Hyman tracks several of the day's top trending stock tickers, including Pfizer (PFE) expects flat sales growth in its 2026 forecast, Kraft Heinz (KHC) names former Kellanova (K) CEO Steve Cahillane as its next chief executive ahead of the food company's split, and PayPal (PYPL) filing for a US bank charter. To watch more expert insights and analysis on the latest market action, check out more Morning Brief.",
      "url": "https://finnhub.io/api/news?id=2194b41863459efcc3280e31a6eaf7be43ef215040cd4a6cc41900814a3dbcde"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer Inc. (PFE) Q4 2026 Guidance Call Transcript",
    "summary": "Pfizer Inc. (PFE) Q4 2026 Guidance Call December 16, 2025 8:00 AM ESTCompany ParticipantsFrancesca DeMartino - Chief Investor Relations OfficerAlbert Bourla...",
    "url": "https://finnhub.io/api/news?id=85c3dc71cd97842d834c76912218131999470771c4c1d4e6973663ad77555a5e",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1765895944,
      "headline": "Pfizer Inc. (PFE) Q4 2026 Guidance Call Transcript",
      "id": 137804512,
      "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
      "related": "PFE",
      "source": "SeekingAlpha",
      "summary": "Pfizer Inc. (PFE) Q4 2026 Guidance Call December 16, 2025 8:00 AM ESTCompany ParticipantsFrancesca DeMartino - Chief Investor Relations OfficerAlbert Bourla...",
      "url": "https://finnhub.io/api/news?id=85c3dc71cd97842d834c76912218131999470771c4c1d4e6973663ad77555a5e"
    }
  },
  {
    "ts": null,
    "headline": "5 High-Risk, High-Reward Biotech Breakthrough Stocks to Watch in 2026",
    "summary": "MindMed and four other biotech disruptors face pivotal studies and FDA decisions in 2026, setting up high-risk, high-reward opportunities for bold investors",
    "url": "https://finnhub.io/api/news?id=9bb80245a64b446ebbcb262a5774e0997879e67f6d707699a528d4054434814d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1765894980,
      "headline": "5 High-Risk, High-Reward Biotech Breakthrough Stocks to Watch in 2026",
      "id": 137804189,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "MindMed and four other biotech disruptors face pivotal studies and FDA decisions in 2026, setting up high-risk, high-reward opportunities for bold investors",
      "url": "https://finnhub.io/api/news?id=9bb80245a64b446ebbcb262a5774e0997879e67f6d707699a528d4054434814d"
    }
  },
  {
    "ts": null,
    "headline": "Wall Street Lunch: Macro Picture Murky After Data Dump",
    "summary": "Latest unemployment rate up to 4.6%, highest since 2021. Analysts cool on ice cream pure play. Howard Stern inks new Sirius deal.",
    "url": "https://finnhub.io/api/news?id=3cee6bc7634d8901e49eac7fbea6aad84ce219c78764c3578e20f5cc8ff86e9a",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1765889690,
      "headline": "Wall Street Lunch: Macro Picture Murky After Data Dump",
      "id": 137803451,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2086435115/image_2086435115.jpg?io=getty-c-w1536",
      "related": "PFE",
      "source": "SeekingAlpha",
      "summary": "Latest unemployment rate up to 4.6%, highest since 2021. Analysts cool on ice cream pure play. Howard Stern inks new Sirius deal.",
      "url": "https://finnhub.io/api/news?id=3cee6bc7634d8901e49eac7fbea6aad84ce219c78764c3578e20f5cc8ff86e9a"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer expects flat revenue in 2026 as Covid-19 product sales weaken",
    "summary": "Pfizer expects flat revenue in 2026 as Covid-19 product sales weaken",
    "url": "https://finnhub.io/api/news?id=5e19c0b8809d8adbc171710b5ad77a57ddb2f2d9bc8bfec26ad419d5b06741f7",
    "source": "Fintel",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1765889629,
      "headline": "Pfizer expects flat revenue in 2026 as Covid-19 product sales weaken",
      "id": 137801697,
      "image": "",
      "related": "PFE",
      "source": "Fintel",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=5e19c0b8809d8adbc171710b5ad77a57ddb2f2d9bc8bfec26ad419d5b06741f7"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer falls on disappointing guidance",
    "summary": "CNBC’s Annika Kim Constantino reports on Pfizer's 2026 guidance.",
    "url": "https://finnhub.io/api/news?id=3cef17db6724491dc87ea6f7bc38d1c6802706471f87c076236fec517756ebd5",
    "source": "CNBC",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1765887677,
      "headline": "Pfizer falls on disappointing guidance",
      "id": 137803200,
      "image": "https://image.cnbcfm.com/api/v1/image/108242497-17659047461765904744-43015990706-1080pnbcnews.jpg?v=1765904745&w=1920&h=1080",
      "related": "PFE",
      "source": "CNBC",
      "summary": "CNBC’s Annika Kim Constantino reports on Pfizer's 2026 guidance.",
      "url": "https://finnhub.io/api/news?id=3cef17db6724491dc87ea6f7bc38d1c6802706471f87c076236fec517756ebd5"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer’s modest 2026 outlook shows its big investments will take time to pay off",
    "summary": "Pfizer has pursued deals of all sizes to build new revenue streams, but the outlook underscores that those investments are still some distance from paying off.",
    "url": "https://finnhub.io/api/news?id=b12d8f7ba204c64349bb0e33dd69338670abfcf3076d4da0d9fa89f79f7e7857",
    "source": "CNBC",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1765879945,
      "headline": "Pfizer’s modest 2026 outlook shows its big investments will take time to pay off",
      "id": 137803201,
      "image": "https://image.cnbcfm.com/api/v1/image/108218653-1761752333854-gettyimages-2243676983-299665final.jpeg?v=1765892129&w=1920&h=1080",
      "related": "PFE",
      "source": "CNBC",
      "summary": "Pfizer has pursued deals of all sizes to build new revenue streams, but the outlook underscores that those investments are still some distance from paying off. ",
      "url": "https://finnhub.io/api/news?id=b12d8f7ba204c64349bb0e33dd69338670abfcf3076d4da0d9fa89f79f7e7857"
    }
  },
  {
    "ts": null,
    "headline": "Stocks making the biggest moves premarket: Pfizer, Roku, Kraft Heinz & more",
    "summary": "These are the stocks posting the largest moves in early trading.",
    "url": "https://finnhub.io/api/news?id=60e1b28ca0cf718d5fc8fad83c57e4d7d58ed92645dabbaa1df1f03e7f919c85",
    "source": "CNBC",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1765870073,
      "headline": "Stocks making the biggest moves premarket: Pfizer, Roku, Kraft Heinz & more",
      "id": 137803202,
      "image": "https://image.cnbcfm.com/api/v1/image/108218653-1761752333854-gettyimages-2243676983-299665final.jpeg?v=1765892129&w=1920&h=1080",
      "related": "PFE",
      "source": "CNBC",
      "summary": "These are the stocks posting the largest moves in early trading. ",
      "url": "https://finnhub.io/api/news?id=60e1b28ca0cf718d5fc8fad83c57e4d7d58ed92645dabbaa1df1f03e7f919c85"
    }
  },
  {
    "ts": null,
    "headline": "UK Gaming Tax Hike And New Director Appointment Might Change The Case For Investing In Flutter Entertainment (FLUT)",
    "summary": "In December 2025, Flutter Entertainment PLC announced that Sally Susman, Pfizer’s Executive Vice President and Chief Corporate Affairs Officer, would join its Board as a non-executive director following the company’s Annual General Meeting on May 29, 2026, bringing extensive global communications and corporate affairs experience from roles at Pfizer, Estée Lauder, and American Express. This appointment comes shortly after the UK Budget introduced sharp increases in online gaming and sports...",
    "url": "https://finnhub.io/api/news?id=df66cf191c4185cda03498c12913a126794be5ac80ba28ab3779f9eef5dbbc3e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1765861546,
      "headline": "UK Gaming Tax Hike And New Director Appointment Might Change The Case For Investing In Flutter Entertainment (FLUT)",
      "id": 137798677,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "In December 2025, Flutter Entertainment PLC announced that Sally Susman, Pfizer’s Executive Vice President and Chief Corporate Affairs Officer, would join its Board as a non-executive director following the company’s Annual General Meeting on May 29, 2026, bringing extensive global communications and corporate affairs experience from roles at Pfizer, Estée Lauder, and American Express. This appointment comes shortly after the UK Budget introduced sharp increases in online gaming and sports...",
      "url": "https://finnhub.io/api/news?id=df66cf191c4185cda03498c12913a126794be5ac80ba28ab3779f9eef5dbbc3e"
    }
  }
]